The 3rd Pharmaceutical Regulatory Affairs Summit Asia is THE meeting place for regulators and RA professionals to discuss and address the latest changes and how to most efficiently negotiate regulatory issues across the region. Country updates and presentations from Indonesia, China, Japan, Philippines, Thailand, Malaysia, Singapore and India will provide an outline of Asia's regulatory landscape. There will also be an in depth look into the developments in guidelines and policies and updates on US FDA and EMEA.

 

It is the ONLY event in ASIA to bring together regulators from Asia's important markets and top Regulatory Affairs Executives from Global Pharmas, Generics Companies and leading Biotechs to discuss regulatory strategy particularly in Clinical Development, Marketing and Biologics/Biosimilars.